SRX Share Price

Open 13.73 Change Price %
High 13.95 1 Day 0.14 1.02
Low 13.73 1 Week 0.00 0.00
Close 13.80 1 Month -1.33 -8.79
Volume 242921 1 Year -14.38 -51.03
52 Week High 28.86
52 Week Low 10.45
SRX Important Levels
Resistance 2 14.00
Resistance 1 13.92
Pivot 13.83
Support 1 13.68
Support 2 13.60
ASX Australia Most Active Stocks
COE 0.30 3.45%
COE 0.30 3.45%
GPP 0.02 0.00%
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
XST 0.02 100.00%
XST 0.02 100.00%
ATP 0.03 50.00%
ATP 0.03 50.00%
PMQ 0.03 50.00%
RMI 0.03 50.00%
RMI 0.03 50.00%
BNV 0.03 50.00%
IRM 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
GDY 0.01 -50.00%
More..

Sirtex Medical Ltd (ASX: SRX)

SRX Technical Analysis 5
As on 1st Nov 2017 SRX Share Price closed @ 13.80 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 15.66 & Strong Sell for SHORT-TERM with Stoploss of 14.64 we also expect STOCK to react on Following IMPORTANT LEVELS.
SRX Target for December
1st Target up-side 14.77
2nd Target up-side 15.55
3rd Target up-side 16.33
1st Target down-side 12.55
2nd Target down-side 11.77
3rd Target down-side 10.99
SRX Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.sirtex.com
SRX Address
SRX
101 Miller Street
Level 33
Sydney, NSW 2060
Australia
Phone: 61 2 9964 8400
Fax: 61 2 9964 8410
SRX Latest News
Interactive Technical Analysis Chart Sirtex Medical Ltd ( SRX ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sirtex Medical Ltd
SRX Business Profile
Sirtex Medical Limited, a biotechnology and medical device company, is engaged in the research, development, manufacture, and distribution of liver cancer treatments utilizing small particle technology. It offers SIR-Spheres microspheres, a medical device used to deliver targeted internal radiation therapy, which contains radioactive yttrium-90 for the treatment of liver cancer. The company markets its products in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. Sirtex Medical Limited has a collaboration agreement with Guerbet S.A. to evaluate the unmet clinical need in patients with hepatocellular carcinoma, metastatic colorectal cancer, neuroendocrine tumors, and a range of other secondary liver cancers. The company is headquartered in Sydney, Australia.